SMAD4 and neoplasm: [31] Indeed, miR-183 has been suggested to be an oncogene in several cancers such as colorectal, lung and hepatocellular, where it regulates diverse mediators of tumor survival and function, including targeting the tumor suppressor Bmi-1, EGR1, PTEN and SMAD4.